Global and United States Immuno-oncology Drugs Market Report & Forecast 2022-2028

Global and United States Immuno-oncology Drugs Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Immuno-oncology Drugs Product Introduction
1.2 Global Immuno-oncology Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Immuno-oncology Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Immuno-oncology Drugs Sales in Volume for the Year 2017-2028
1.3 United States Immuno-oncology Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Immuno-oncology Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Immuno-oncology Drugs Sales in Volume for the Year 2017-2028
1.4 Immuno-oncology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Immuno-oncology Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Immuno-oncology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Immuno-oncology Drugs Market Dynamics
1.5.1 Immuno-oncology Drugs Industry Trends
1.5.2 Immuno-oncology Drugs Market Drivers
1.5.3 Immuno-oncology Drugs Market Challenges
1.5.4 Immuno-oncology Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Immuno-oncology Drugs Market Segment by Type
2.1.1 Immune Checkpoint Inhibitors
2.1.2 Immune System Modulators
2.1.3 Cancer Vaccines
2.1.4 Oncolytic Virus
2.1.5 Others
2.2 Global Immuno-oncology Drugs Market Size by Type
2.2.1 Global Immuno-oncology Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Immuno-oncology Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Immuno-oncology Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Immuno-oncology Drugs Market Size by Type
2.3.1 United States Immuno-oncology Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Immuno-oncology Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Immuno-oncology Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Immuno-oncology Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Immuno-oncology Drugs Market Size by Application
3.2.1 Global Immuno-oncology Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Immuno-oncology Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Immuno-oncology Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Immuno-oncology Drugs Market Size by Application
3.3.1 United States Immuno-oncology Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Immuno-oncology Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Immuno-oncology Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Immuno-oncology Drugs Competitor Landscape by Company
4.1 Global Immuno-oncology Drugs Market Size by Company
4.1.1 Top Global Immuno-oncology Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Immuno-oncology Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Immuno-oncology Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Immuno-oncology Drugs Price by Manufacturer (2017-2022)
4.2 Global Immuno-oncology Drugs Concentration Ratio (CR)
4.2.1 Immuno-oncology Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Immuno-oncology Drugs in 2021
4.2.3 Global Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Immuno-oncology Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Immuno-oncology Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Immuno-oncology Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Immuno-oncology Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Immuno-oncology Drugs Market Size by Company
4.5.1 Top Immuno-oncology Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Immuno-oncology Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Immuno-oncology Drugs Sales by Players (2020, 2021 & 2022)
5 Global Immuno-oncology Drugs Market Size by Region
5.1 Global Immuno-oncology Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Immuno-oncology Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Immuno-oncology Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Immuno-oncology Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Immuno-oncology Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Immuno-oncology Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Immuno-oncology Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Immuno-oncology Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Immuno-oncology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Immuno-oncology Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Immuno-oncology Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Immuno-oncology Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Immuno-oncology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Immuno-oncology Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Immuno-oncology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Immuno-oncology Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Immuno-oncology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Amgen, Inc
7.1.1 Amgen, Inc Corporation Information
7.1.2 Amgen, Inc Description and Business Overview
7.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Amgen, Inc Immuno-oncology Drugs Products Offered
7.1.5 Amgen, Inc Recent Development
7.2 AstraZeneca, Plc
7.2.1 AstraZeneca, Plc Corporation Information
7.2.2 AstraZeneca, Plc Description and Business Overview
7.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 AstraZeneca, Plc Immuno-oncology Drugs Products Offered
7.2.5 AstraZeneca, Plc Recent Development
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporation Information
7.3.2 Bristol-Myers Squibb Description and Business Overview
7.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Products Offered
7.3.5 Bristol-Myers Squibb Recent Development
7.4 Celgene Corporation
7.4.1 Celgene Corporation Corporation Information
7.4.2 Celgene Corporation Description and Business Overview
7.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Celgene Corporation Immuno-oncology Drugs Products Offered
7.4.5 Celgene Corporation Recent Development
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Corporation Information
7.5.2 Eli Lilly and Company Description and Business Overview
7.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Eli Lilly and Company Immuno-oncology Drugs Products Offered
7.5.5 Eli Lilly and Company Recent Development
7.6 Merck & Co.
7.6.1 Merck & Co. Corporation Information
7.6.2 Merck & Co. Description and Business Overview
7.6.3 Merck & Co. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Merck & Co. Immuno-oncology Drugs Products Offered
7.6.5 Merck & Co. Recent Development
7.7 Hoffmann-La Roche AG
7.7.1 Hoffmann-La Roche AG Corporation Information
7.7.2 Hoffmann-La Roche AG Description and Business Overview
7.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Products Offered
7.7.5 Hoffmann-La Roche AG Recent Development
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Corporation Information
7.8.2 Johnson & Johnson Description and Business Overview
7.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Johnson & Johnson Immuno-oncology Drugs Products Offered
7.8.5 Johnson & Johnson Recent Development
7.9 Novartis International AG
7.9.1 Novartis International AG Corporation Information
7.9.2 Novartis International AG Description and Business Overview
7.9.3 Novartis International AG Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Novartis International AG Immuno-oncology Drugs Products Offered
7.9.5 Novartis International AG Recent Development
7.10 AbbVie, Inc.
7.10.1 AbbVie, Inc. Corporation Information
7.10.2 AbbVie, Inc. Description and Business Overview
7.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AbbVie, Inc. Immuno-oncology Drugs Products Offered
7.10.5 AbbVie, Inc. Recent Development
7.11 Pfizer Inc.
7.11.1 Pfizer Inc. Corporation Information
7.11.2 Pfizer Inc. Description and Business Overview
7.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Pfizer Inc. Immuno-oncology Drugs Products Offered
7.11.5 Pfizer Inc. Recent Development
7.12 Sanofi S.A.
7.12.1 Sanofi S.A. Corporation Information
7.12.2 Sanofi S.A. Description and Business Overview
7.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Sanofi S.A. Products Offered
7.12.5 Sanofi S.A. Recent Development
7.13 EMD Serono, Inc.
7.13.1 EMD Serono, Inc. Corporation Information
7.13.2 EMD Serono, Inc. Description and Business Overview
7.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 EMD Serono, Inc. Products Offered
7.13.5 EMD Serono, Inc. Recent Development
7.14 Gilead Sciences Inc.
7.14.1 Gilead Sciences Inc. Corporation Information
7.14.2 Gilead Sciences Inc. Description and Business Overview
7.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Gilead Sciences Inc. Products Offered
7.14.5 Gilead Sciences Inc. Recent Development
7.15 Prometheus Therapeutics & Diagnostics
7.15.1 Prometheus Therapeutics & Diagnostics Corporation Information
7.15.2 Prometheus Therapeutics & Diagnostics Description and Business Overview
7.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Prometheus Therapeutics & Diagnostics Products Offered
7.15.5 Prometheus Therapeutics & Diagnostics Recent Development
7.16 Aduro BioTech
7.16.1 Aduro BioTech Corporation Information
7.16.2 Aduro BioTech Description and Business Overview
7.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Aduro BioTech Products Offered
7.16.5 Aduro BioTech Recent Development
7.17 Galena Biopharma
7.17.1 Galena Biopharma Corporation Information
7.17.2 Galena Biopharma Description and Business Overview
7.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Galena Biopharma Products Offered
7.17.5 Galena Biopharma Recent Development
7.18 Bavarian Nordic
7.18.1 Bavarian Nordic Corporation Information
7.18.2 Bavarian Nordic Description and Business Overview
7.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Bavarian Nordic Products Offered
7.18.5 Bavarian Nordic Recent Development
7.19 Celldex Therapeutics
7.19.1 Celldex Therapeutics Corporation Information
7.19.2 Celldex Therapeutics Description and Business Overview
7.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Celldex Therapeutics Products Offered
7.19.5 Celldex Therapeutics Recent Development
7.20 ImmunoCellular Therapeutics
7.20.1 ImmunoCellular Therapeutics Corporation Information
7.20.2 ImmunoCellular Therapeutics Description and Business Overview
7.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.20.4 ImmunoCellular Therapeutics Products Offered
7.20.5 ImmunoCellular Therapeutics Recent Development
7.21 Incyte
7.21.1 Incyte Corporation Information
7.21.2 Incyte Description and Business Overview
7.21.3 Incyte Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Incyte Products Offered
7.21.5 Incyte Recent Development
7.22 Dendreon Corporation
7.22.1 Dendreon Corporation Corporation Information
7.22.2 Dendreon Corporation Description and Business Overview
7.22.3 Dendreon Corporation Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.22.4 Dendreon Corporation Products Offered
7.22.5 Dendreon Corporation Recent Development
7.23 Agilent Technologies Inc.
7.23.1 Agilent Technologies Inc. Corporation Information
7.23.2 Agilent Technologies Inc. Description and Business Overview
7.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.23.4 Agilent Technologies Inc. Products Offered
7.23.5 Agilent Technologies Inc. Recent Development
7.24 Agenus Inc.
7.24.1 Agenus Inc. Corporation Information
7.24.2 Agenus Inc. Description and Business Overview
7.24.3 Agenus Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.24.4 Agenus Inc. Products Offered
7.24.5 Agenus Inc. Recent Development
7.25 Enzo Biochem, Inc.
7.25.1 Enzo Biochem, Inc. Corporation Information
7.25.2 Enzo Biochem, Inc. Description and Business Overview
7.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.25.4 Enzo Biochem, Inc. Products Offered
7.25.5 Enzo Biochem, Inc. Recent Development
7.26 Lonza Group
7.26.1 Lonza Group Corporation Information
7.26.2 Lonza Group Description and Business Overview
7.26.3 Lonza Group Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.26.4 Lonza Group Products Offered
7.26.5 Lonza Group Recent Development
7.27 Bio-Rad Laboratories, Inc.
7.27.1 Bio-Rad Laboratories, Inc. Corporation Information
7.27.2 Bio-Rad Laboratories, Inc. Description and Business Overview
7.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.27.4 Bio-Rad Laboratories, Inc. Products Offered
7.27.5 Bio-Rad Laboratories, Inc. Recent Development
7.28 Avantor, Inc.
7.28.1 Avantor, Inc. Corporation Information
7.28.2 Avantor, Inc. Description and Business Overview
7.28.3 Avantor, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.28.4 Avantor, Inc. Products Offered
7.28.5 Avantor, Inc. Recent Development
7.29 Spring Bank Pharmaceuticals, Inc.
7.29.1 Spring Bank Pharmaceuticals, Inc. Corporation Information
7.29.2 Spring Bank Pharmaceuticals, Inc. Description and Business Overview
7.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.29.4 Spring Bank Pharmaceuticals, Inc. Products Offered
7.29.5 Spring Bank Pharmaceuticals, Inc. Recent Development
7.30 Ferring Pharmaceuticals
7.30.1 Ferring Pharmaceuticals Corporation Information
7.30.2 Ferring Pharmaceuticals Description and Business Overview
7.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.30.4 Ferring Pharmaceuticals Products Offered
7.30.5 Ferring Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Immuno-oncology Drugs Industry Chain Analysis
8.2 Immuno-oncology Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Immuno-oncology Drugs Distributors
8.3 Immuno-oncology Drugs Production Mode & Process
8.4 Immuno-oncology Drugs Sales and Marketing
8.4.1 Immuno-oncology Drugs Sales Channels
8.4.2 Immuno-oncology Drugs Distributors
8.5 Immuno-oncology Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Immuno-oncology Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Immuno-oncology Drugs Market Trends
Table 3. Immuno-oncology Drugs Market Drivers
Table 4. Immuno-oncology Drugs Market Challenges
Table 5. Immuno-oncology Drugs Market Restraints
Table 6. Global Immuno-oncology Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Immuno-oncology Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Immuno-oncology Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Immuno-oncology Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Immuno-oncology Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Immuno-oncology Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Immuno-oncology Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Immuno-oncology Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Immuno-oncology Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Immuno-oncology Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Immuno-oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Immuno-oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Drugs as of 2021)
Table 18. Top Players of Immuno-oncology Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Immuno-oncology Drugs Product Type
Table 20. Date of International Manufacturers Enter into Immuno-oncology Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Immuno-oncology Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Immuno-oncology Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Immuno-oncology Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Immuno-oncology Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Immuno-oncology Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Immuno-oncology Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Immuno-oncology Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Immuno-oncology Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Immuno-oncology Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Immuno-oncology Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Immuno-oncology Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Immuno-oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Immuno-oncology Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Immuno-oncology Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Immuno-oncology Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Immuno-oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Immuno-oncology Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Immuno-oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Immuno-oncology Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Immuno-oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Amgen, Inc Corporation Information
Table 43. Amgen, Inc Description and Business Overview
Table 44. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Amgen, Inc Immuno-oncology Drugs Product
Table 46. Amgen, Inc Recent Development
Table 47. AstraZeneca, Plc Corporation Information
Table 48. AstraZeneca, Plc Description and Business Overview
Table 49. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. AstraZeneca, Plc Product
Table 51. AstraZeneca, Plc Recent Development
Table 52. Bristol-Myers Squibb Corporation Information
Table 53. Bristol-Myers Squibb Description and Business Overview
Table 54. Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Bristol-Myers Squibb Product
Table 56. Bristol-Myers Squibb Recent Development
Table 57. Celgene Corporation Corporation Information
Table 58. Celgene Corporation Description and Business Overview
Table 59. Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Celgene Corporation Product
Table 61. Celgene Corporation Recent Development
Table 62. Eli Lilly and Company Corporation Information
Table 63. Eli Lilly and Company Description and Business Overview
Table 64. Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Eli Lilly and Company Product
Table 66. Eli Lilly and Company Recent Development
Table 67. Merck & Co. Corporation Information
Table 68. Merck & Co. Description and Business Overview
Table 69. Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Merck & Co. Product
Table 71. Merck & Co. Recent Development
Table 72. Hoffmann-La Roche AG Corporation Information
Table 73. Hoffmann-La Roche AG Description and Business Overview
Table 74. Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Hoffmann-La Roche AG Product
Table 76. Hoffmann-La Roche AG Recent Development
Table 77. Johnson & Johnson Corporation Information
Table 78. Johnson & Johnson Description and Business Overview
Table 79. Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Johnson & Johnson Product
Table 81. Johnson & Johnson Recent Development
Table 82. Novartis International AG Corporation Information
Table 83. Novartis International AG Description and Business Overview
Table 84. Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Novartis International AG Product
Table 86. Novartis International AG Recent Development
Table 87. AbbVie, Inc. Corporation Information
Table 88. AbbVie, Inc. Description and Business Overview
Table 89. AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. AbbVie, Inc. Product
Table 91. AbbVie, Inc. Recent Development
Table 92. Pfizer Inc. Corporation Information
Table 93. Pfizer Inc. Description and Business Overview
Table 94. Pfizer Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Pfizer Inc. Product
Table 96. Pfizer Inc. Recent Development
Table 97. Sanofi S.A. Corporation Information
Table 98. Sanofi S.A. Description and Business Overview
Table 99. Sanofi S.A. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Sanofi S.A. Product
Table 101. Sanofi S.A. Recent Development
Table 102. EMD Serono, Inc. Corporation Information
Table 103. EMD Serono, Inc. Description and Business Overview
Table 104. EMD Serono, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. EMD Serono, Inc. Product
Table 106. EMD Serono, Inc. Recent Development
Table 107. Gilead Sciences Inc. Corporation Information
Table 108. Gilead Sciences Inc. Description and Business Overview
Table 109. Gilead Sciences Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Gilead Sciences Inc. Product
Table 111. Gilead Sciences Inc. Recent Development
Table 112. Prometheus Therapeutics & Diagnostics Corporation Information
Table 113. Prometheus Therapeutics & Diagnostics Description and Business Overview
Table 114. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Prometheus Therapeutics & Diagnostics Product
Table 116. Prometheus Therapeutics & Diagnostics Recent Development
Table 117. Aduro BioTech Corporation Information
Table 118. Aduro BioTech Description and Business Overview
Table 119. Aduro BioTech Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Aduro BioTech Product
Table 121. Aduro BioTech Recent Development
Table 122. Galena Biopharma Corporation Information
Table 123. Galena Biopharma Description and Business Overview
Table 124. Galena Biopharma Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Galena Biopharma Product
Table 126. Galena Biopharma Recent Development
Table 127. Bavarian Nordic Corporation Information
Table 128. Bavarian Nordic Description and Business Overview
Table 129. Bavarian Nordic Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Bavarian Nordic Product
Table 131. Bavarian Nordic Recent Development
Table 132. Celldex Therapeutics Corporation Information
Table 133. Celldex Therapeutics Description and Business Overview
Table 134. Celldex Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Celldex Therapeutics Product
Table 136. Celldex Therapeutics Recent Development
Table 137. ImmunoCellular Therapeutics Corporation Information
Table 138. ImmunoCellular Therapeutics Description and Business Overview
Table 139. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. ImmunoCellular Therapeutics Product
Table 141. ImmunoCellular Therapeutics Recent Development
Table 142. Incyte Corporation Information
Table 143. Incyte Description and Business Overview
Table 144. Incyte Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Incyte Product
Table 146. Incyte Recent Development
Table 147. Dendreon Corporation Corporation Information
Table 148. Dendreon Corporation Description and Business Overview
Table 149. Dendreon Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Dendreon Corporation Product
Table 151. Dendreon Corporation Recent Development
Table 152. Agilent Technologies Inc. Corporation Information
Table 153. Agilent Technologies Inc. Description and Business Overview
Table 154. Agilent Technologies Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Agilent Technologies Inc. Product
Table 156. Agilent Technologies Inc. Recent Development
Table 157. Agenus Inc. Corporation Information
Table 158. Agenus Inc. Description and Business Overview
Table 159. Agenus Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. Agenus Inc. Product
Table 161. Agenus Inc. Recent Development
Table 162. Enzo Biochem, Inc. Corporation Information
Table 163. Enzo Biochem, Inc. Description and Business Overview
Table 164. Enzo Biochem, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 165. Enzo Biochem, Inc. Product
Table 166. Enzo Biochem, Inc. Recent Development
Table 167. Lonza Group Corporation Information
Table 168. Lonza Group Description and Business Overview
Table 169. Lonza Group Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 170. Lonza Group Product
Table 171. Lonza Group Recent Development
Table 172. Bio-Rad Laboratories, Inc. Corporation Information
Table 173. Bio-Rad Laboratories, Inc. Description and Business Overview
Table 174. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 175. Bio-Rad Laboratories, Inc. Product
Table 176. Bio-Rad Laboratories, Inc. Recent Development
Table 177. Avantor, Inc. Corporation Information
Table 178. Avantor, Inc. Description and Business Overview
Table 179. Avantor, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 180. Avantor, Inc. Product
Table 181. Avantor, Inc. Recent Dev

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs